H
uman immunoddidency viruses (HIV-1 and HIV-2) are known to infect in vivo cells bearing the CD4 glycoprotein surface receptor (1) . These indude both T helper lymphocytes and also cells of the monocyte/macrophage series. Infection of these cells is believed to be the major cause of immune deficiency seen in the later stages of HIV infection. However, several other cell types are known to express membrane CD4 and are, therefore, potential targets for HIV infection. For example, eosinophils isolated from peripheral blood of patients with eosinophilia have been shown to express CD4 on their surface, to which HIV-1 gp 120 will bind in vitro (2) , although HIV infection of these cells has not previously been reported.
Eosinophils are granulocytic leukocytes derived from bone marrow stem cells and, like macrophages, they migrate rapidly from peripheral blood into tissues, where they may survive for several weeks (3) . Although in vivo functions of eosinophils are not fully understood, their numbers, both in blood and tissues, increase greatly in response to parasitic infections (4) . Thus, the possibility that eosinophils are infected by HIV in vivo would have important implications for the pathogenesis of HIV disease, particularly in tropical countries where both HIV and parasitic infections are widespread. For this reason we have investigated the potential for eosinophils to support HIV infection by attempting to infect normal human eosinophil precursors with HIV-1 strains in vitro.
Materials and Methods
Bone Marrow Culture and Infection with HIVI. Normal human bone marrow samples were obtained, with informed consent, from five healthy volunteers by iliac crest aspiration. Mononuclear cells were separated by centtifugation over HcoH and suspended in IMDM containing 15% FCS, at 10 ~ cells/ml. Human rlL-5 (Glaxo Group Research Ltd., Greenford, UK) was added at 2 ng/ml to promote eosinophil differentiation (5) . Cells were cultured for up to 56 d in 96-well microtitre plates (I(P cells in 100/~l/well), at 37~ in 95% air/5% COs. To infect the cultured cells with HIV, cell-free supernatants of the R.F, RUT, and IIIB strains of HIV-1 (MILC AIDS Directed Programme) were added at a concentration of 104 tissue culture infectious doses (TCtD)/ml, 7-21 d after the start of the cultures.
Detection of Eosinophil CD4, HIV Antigens, and RNA. Antigen expression by the maturing eosinophil precursors was detected by immunostaining of cytospin slides prepared at 7-d intervals, using the alkaline phosphatase anti-alkaline phosphatase technique with fast red substrate and hematoxylin counterstain (6) . Separate slides at each time-point were stained with mAbs to CD4 (Dakopatts, High Wycombe, UK), and HIV p24 core protein (MRC EH12) and gp41/160 envelope glycoprotein (MtLC ADP330). The percentage of maturing eosinophils expressing CD4 was determined as a function of time in control, uninfected cultures by examining 100 cells on each slide. CD4 expression was quantitated by scoring each cell on an arbitrary scale from 0 to 3 according to the intensity of staining by anti-CD4 antibody. HIV-1 RNA was detected in infected cells by in situ hybridization using a specific 3sS-DNA probe (BH10), with carbol chromotrope treatment to block nonspecific staining of eosinophils (7) .
Detection of ViralReI~lication. 50-/zl aliquots of culture supernatant was removed from each well at weekly intervals and replaced with fresh medium. Supernatants were stored at -70~ and subsequently assayed for reverse transcriptase (KT) activity (8), for HIV p24 antigen level measured by F.LISA (Coulter Immunology, l.uton, UK) and for infectivity, assessed by coculture with Jurkat T cells. Supematants from the cocultures were assayed for I~T activity at dayS. ~eSll|tS Bone Marrow Culture and Eosinophil CD4 Expression. After 21 d in culture, >95% of surviving calls were eosinophil precursors. These ceils developed gradually from early promyelocytes seen at day 7, through to mature, terminally differentiated eosinophils after 56 d in culture, as assessed morphologically. CD4 expression by control, uninfected eosinophil precursors was maximal in terms of both percentage and intensity during the first 28 d in culture, with a gradual decline to almost undetectable levels by 56 d (Fig. 1) .
HIV Antigen and RNA Expression by Eosinophils. Fig. 2 shows a 35-d-old culture, 21 d after infection with HIV-1 ILF strain, stained as described above for p24 antigen. Infected eosinophils expressed p24 predominantly on their cell membrane and a similar pattern was observed when stained for gp41/160. In situ hybridization confirmed the presence of HIV RNA in infected eosinophils (Fig. 3) . Control, uninfected cultures were negative for both HIV antigen and RNA expression (not shown). Eosinophil precursors first showed evidence of infection 14 d after the addition of viral inoculum. A maximum of 4% of the cells stained positively for either antigen or RNA. Infection of eosinophils was observed in two cultures infected with HIV-1 RF strain and one with 
Viral Replication. Productive infection of eosinophil cul-
tures was confirmed by rising levels of IKT activity in the supernatant, beginning 7 d after viral inoculation and continuing up to 49 d after inoculation, by which time all surviving eosinophils were morphologically mature (Fig. 4) . No RT activity was detected in control culture supernatant. Par- 
Days after inoculation
IKT activity in eosinophil culture supernatant after infection with HIV-1. Normal human bone marrow was cultured in the presence of 1I.-5 and inoculated with HIV-1 RF supernatant after 14 d. Culture supernatant was withdrawn at weekly intervals and assayed for RT activity as described. RT activity (cpm/ml) is plotted against days after inoculation.
aUel rises in p24 antigen levels were found in the infected culture supernatants (data not shown). Jurkat cocuhure experiments confirmed the presence of infectious virus in the supernatants for up to 42 d after infection.
Discussion
These studies have shown for the first time that eosinophils can be infected by HIV-1 and support active replication of the virus, thus extending the work of Lucey et al. (2) . We chose to use Ib5-stimulated bone marrow cultures as a source of actively dividing eosinophil precursors, in view of the difficulties associated with obtaining purified peripheral blood eosinophils from normal individuals in sufficient quantities (9) . We carried out preliminary experiments on peripheral blood eosinophils isolated from hyper-eosinophilic subjects, but were unable to infect such cells with HIV or to transfect them with HIV-LTR CAT constructs. In addition, the presence of IL-5 in the culture medium has been found to activate eosinophils (10, 11) and, by analogy with macrophages (12), this would be expected to enhance HIV replication within them.
We found that CD4 expression by eosinophil precursors was greatest early in their maturation, with only very weak expression after 28 d in culture. This decline in CD4 expression occurred in the absence of HIV which, itself, is known to downregulate CD4 expression on infected cells (13) . We, therefore, inoculated the cultures with HIV within the first 21 d in order to maximize the chance of achieving infection, although in vitro infection by HIV-1 of a purified CD34 + / CD4-myeloid progenitor population has been reported (14, 15) , suggesting that CD4 expression may not be necessary. Although only up to 4% of eosinophils in culture expressed HIV antigens or RNA, none of the other contaminating cells, which comprised <5% of the total, were infected, confirming that the viral activity detected in the culture supernatants was due to viral replication within eosinophils. Typical bilobed nuclear morphology was observed in all eosinophils after day 49 in culture. The increase in RT and p24 activity within the culture supernatant between days 49 and 63 in culture (days 35-49 after inoculation) provides strong evidence of continuing HIV replication in such mature cells.
The ability of RF and RUT, but not 11113, strains of HIV-1 to infect eosinophils suggests that, as for macrophages (16) and megakaryocytes (17) , there may be strains of HIV with tropism for eosinophils. The latter is a laboratory adapted T lymphocyte tropic strain, which failed to infect CD34 § myeloid precursors in vitro (15) . Eosinophils are known to have many similarities to macrophages, including their tropism for the skin and mucosal tissues and their activation by cytokines (18) . Like macrophages, they may also be a major reservoir for HIV, but further studies will be required to elucidate their role in vivo.
